-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, ET3Td8lcY4o6dTT5+3klH72e8vUDqH70+c1hj/Y/aSBHoE8rqs/k1Wr0z9BF5Q4J MrqM1L2In8iw3n/WW3SusQ== 0001038133-04-000035.txt : 20041216 0001038133-04-000035.hdr.sgml : 20041216 20041215183746 ACCESSION NUMBER: 0001038133-04-000035 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20041215 ITEM INFORMATION: Entry into a Material Definitive Agreement FILED AS OF DATE: 20041216 DATE AS OF CHANGE: 20041215 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HESKA CORP CENTRAL INDEX KEY: 0001038133 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 770192527 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-72155 FILM NUMBER: 041206004 BUSINESS ADDRESS: STREET 1: 1613 PROSPECT PARKWAY CITY: FORT COLLINS STATE: CO ZIP: 80525 BUSINESS PHONE: 9704937272 MAIL ADDRESS: STREET 1: 1613 PROSPECT PARKWAY CITY: FORT COLLINS STATE: CO ZIP: 80525 8-K 1 heska8kagreement.htm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

December 10, 2004
Date of Report (Date of earliest event reported)

HESKA CORPORATION
(Exact name of Registrant as specified in its charter)


Delaware

000-22427
77-0192527
(State or other jurisdiction of (Commission File Number) (I.R.S. Employer
incorporation)   Identification Number)

1613 Prospect Parkway
Fort Collins, Colorado 80525
(Address of principal executive offices, including zip code)

(970) 493-7272
(Registrant’s telephone number, including area code)

Not Applicable
(Former name or former address, if changed since last report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):

[  ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[  ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[  ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[  ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Item 1.01.       Entry into a Material Definitive Agreement.

        On December 10, 2004, Diamond Animal Health, Inc., a subsidiary of Heska Corporation (“Heska”), entered into the Second Amendment to the Amended and Restated Bovine Vaccine Distribution Agreement dated September 30, 2002 (the “Amendment”) with Agri Laboratories, Ltd. The material terms of the Amendment are described in the press release issued by Heska on December 13, 2004, a copy of which is included as Exhibit 99.1 to this report and incorporated herein by reference.

Item 9.01.       Financial Statements and Exhibits.

               (c)     Exhibits.

               99.1   Press Release dated December 13, 2004 issued by Heska.


SIGNATURES

        Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    HESKA CORPORATION


Dated:          December 15, 2004
 
By: /s/Jason A. Napolitano     
JASON A. NAPOLITANO
Executive Vice President, Chief Financial Officer
and Secretary
EX-99.1 2 pressrelease.htm PRESS RELEASE

Exhibit 99.1

 

 

 

FOR IMMEDIATE RELEASE

 

At Heska Corporation:
Jason Napolitano, Executive Vice President & CFO
    (970) 493-7272, Ext. 4105

 

Heska Corporation Announces Amended Agreement with AgriLabs


FORT COLLINS, CO, December 13, 2004 — Heska Corporation (NASDAQ: HSKA) today announced that an amendment to the current distribution agreement with Agri Laboratories, Ltd., or AgriLabs, has been signed. Under the amendment, currently outstanding prepayments from AgriLabs will be considered an upfront fee and the pricing on certain products has been increased. AgriLabs’ minimums to maintain exclusivity on certain bovine vaccines have been significantly reduced and no longer increase annually, although the minimums are subject to adjustment in certain circumstances.

Under the amendment, AgriLabs will continue to enjoy access to these bovine vaccines in the United States, Africa, China, Mexico and Taiwan to December 2013. Subject to minimum purchase requirements, AgriLabs’ rights in these regions will be exclusive at least to December 2009 and could remain exclusive up to December 2013 based on other contractual arrangements. Heska will be free to sell these bovine vaccines to any party of its choosing in other regions of the world. AgriLabs will also maintain non-exclusive rights to these bovine vaccines in Canada to December 2009.

In addition, two separate research and development agreements have been signed with AgriLabs. These agreements specified risk sharing provisions where AgriLabs has agreed to fund the initial research and development expenditures, but will be entitled to certain additional product rights and/or reimbursement of expenditures under certain circumstances. The research and development programs are intended to enhance the quality of the current line of bovine vaccines.

“We are pleased we have found a mutually agreeable solution to this matter,” said Robert Grieve, Heska’s Chairman and CEO. “AgriLabs has been an excellent customer of ours in the past and we are happy we will continue to benefit from their livestock market expertise in the future.”

“We have long been impressed with these vaccines, which we sell under our label and tradenames Titanium® and MasterGuard®,” said Steve Schram, AgriLabs’s President and CEO. “We are hopeful that the research and development agreements we have signed will allow us to maintain the leadership position we have established in the marketplace with these vaccines.”

About Heska
Heska Corporation (NASDAQ: HSKA) sells advanced veterinary diagnostic and other specialty veterinary products. Heska’s state-of-the-art offerings to its customers include diagnostic and monitoring instruments and supplies as well as single use, point-of-care tests, vaccines and pharmaceuticals. The company’s core focus is on the canine and feline markets where it strives to develop high value products for unmet needs in veterinary medicine. For further information on Heska and its products, visit the company’s website at www.heska.com.

About AgriLabs
AgriLabs, Ltd. is the largest private label marketer of veterinary vaccines and pharmaceuticals in the United States. AgriLabs is proficient in sales, marketing and technology transfer of current and future compounds or antigens for both food and companion animal markets. The AgriLabs distribution network of distributor owners is the largest in the United States and has the ability to efficiently reach the livestock and consumer marketplace through various veterinary, direct and retail channels. For additional information on AgriLabs and its products or distributors, visit the company website at www.agrilabs.com.

Forward-Looking Statements
This announcement contains express or implied forward-looking information about Heska’s products, business relationships and research and development activities. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause Heska’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Heska’s achievement of these results may be affected by many factors, including among others, the following: uncertainties relating to reliance on the sales and marketing efforts of a third party, over which Heska has no direct control; competition; uncertainties regarding the outcome of research and development projects currently contemplated; delays in or failure to achieve market acceptance of any products resulting from such research and development activities; the failure of third party distribution network members who have purchased large quantities of Heska’s products in the past to continue to do so in the future; uncertainties related to Heska’s ability to obtain and maintain costly regulatory approvals for its products; uncertainties related to Heska’s ability to successfully market and sell its current and any future products, including in nations where such products are not currently sold; reliance on key personnel; and the risks set forth in Heska’s filings and future filings with the Securities and Exchange Commission, including those set forth in Heska’s Annual Report on Form 10-K for the year ended December 31, 2003 and Quarterly Report on Form 10-Q for the quarter ended September 30, 2004.


###
GRAPHIC 3 logo.jpg GRAPHIC begin 644 logo.jpg M_]C_X``02D9)1@`!`0$`E@"6``#__@`<4V]F='=A[LOU0\*?Z0-+W=E^J'A3_`$@:7N[+]4/"G^D#2]W9?JAX4_T@ M:7N[+]4/"G^D#2]W9?JAX5Z0L'M7__5N1OX1[%^ MHB(B(B(B(B(B(B(B(B(B(B(B(B__UKE1$1$1$1$1$1$1$1$1$1$1$1$1$7__ MU[E1$1$1$1$1$1$1$1$1$1$1$1$1%J-6?Q1N_P#4I?[A7__0IE$`)(`&2>I6 MSH#DB=4L9>M5-YBD:-ME(\[)>..7_JM]7'V*>:@TOIOE&TTUMLGIMJES'255 M.!B(C]`@?H^KWA4M;.374=RU+-8S2&!],\"HG>/NXV]3L]>1PQQ5N1/T=R/6 M@Q.E$UPE;EV`#/.?9^BW\O:H,WEQO3M315CZ>-EJ:=E]&W>2T]>U^M^2LJ^: M?L7*78Z2Y44[.>80^EJVC>W!R6.'9VCJ*F(W``]B_41$1$1$1$1$1$1$1$1$ M1?_1N5$1$1$1$1$1$1$1$1$1$1$1$1$1?__2N5$1$1$1$1$1$1$1$1$1$1$1 M$1$1?__3N5$1$1%J-6?Q1N_]2E_N%OU)IWDRHWV M_30BNM]>TMJ+B\9CC/8WM]@]Y*KFON%RU!Q?J(B(B(B(O_7N5$1$1$1$1$1$1$1$1$1$1$1 M$1$1?__0N5$1$1$1$1$1$1$1$1$1$1$1$1$1?__1N5$1$1$1$1$1$1$1$1%K MM0MIWZG*P;E%%DTMPGHF.\E/-2/&#*W\>.P'J]RQN*(LVV,MPEY^YR2&"/?S,/X MY3V`\&CM/Y+/O>K;A>*:.@8&4-LAW0T--YL;1VGK/?N49_?"UAWBKOFKRJ=<:JJXQ'-J" MX%H.=T[F_L70?)IJ(ZDT51U$LO.54`YBH).3M-X$^T8/O4K6-<:>>KMM334U M0:::6)S&3`9,9(P'8]2IBXZ&Y3[$YU1;K]57%H!_@JM^UC^B\_LRH74:ZUO2 M3OIZF^7*&5APZ.1Y:YI]8*^Z'6>N[G61T=#>KE45$IPR.-Y)<585!R>]7U-%C'W<<[WO`Z\[)`S[RK9I(/):.&GYQ\G-1M9MO.7.P,9)[5[(B(B( MB(B(B(B(B__5N5%K[]25]?9*JEM=8**LE9LQ5!!^[.>.Y4]>['RN6:-\S+O5 MU\+,DNI9RYV/Z)P?@H2_E`UE&\L?J"X-@W*=WW'S7_`.2=!N4[ON/FO_R58U.N M]:4E5+32ZAKA)"]S'#G>L'!5Q\C=UN]YTQ5UEWK)JMQJRV*25VT=D-;D#WJP M41$1$1$1$1$1$1$1$1$7_]:Y41$1$1$1$11#]]/27E_D'E\GE//\QS?,._'M M;/'&.*EZ(M9?]16W3-O%?=9G14YD$>TUA=O/#TK71T5VJ9(II(^<:&Q.<-G..(]BU/[\FBO3Y_IW_Y) M^_)HKT^?Z=_^2V=@Y1-.:FN8MUKJ99:@L+\.A?:I,YS6-+G.#6M&22 M<`!0VZG+35V:[T\9/XY*<`?M4CT M[KS3FJ'B*V7!KJC!/D\H+)/<#Q]RV-]OUOTW;'7&YRNBIFO:PN:TNP2<#<%A M:>UK8M55$\%GJG3OIVA\F8W-`!.!Q"WR+44NJK)67^:Q4]PBDKX&[3X@?B`> M!(ZQU+;JI]?SL*WZ(O_U[E1$1$1$1$1$18-[JX*&Q5U54XYF*G>Y^>!&R=R MY4=8ZPZ=-_V,49JO)@>O:V=KX+6JTN0O4`HM05-DE>1'7LVXAG<)&_YMS\%? M*(J2Y?H*1E=:9F,8*N2.02.'XG,!&,^_*D/(MI..UZ=^W:B)IJ[AOC<1O9$. M`'MX_!68B(B(B(B(B__0N5$1$1$1$1<_2@U):,;1).SGU MX_P5:J]^0BQ^2V"LO,C;C)'Z#/\R3\%:B+F?E8LCK+KRM(81#6GRF,X MW':_%_U95I\AW\0G?UR3]C58J(B(B(B(B(B(B+__T;E1$1$1$1$1$1$1$1%R MF?\`:(?_`+M_^5=6(BKKEQ_B$W^N1_L2FTY22NBBEBYZI+3@R`G#6^S<2?< MIGRGAJH70U$+)HWC#F2-#@1 M["HAI_DVMFG-8U=\H@UL,L6S!3X_@'$^<0>SACLR5B\M/^SJH_K$7]Y0S]S_ M`/\`NUX_X$?]XK__TKC>]D;'/D<&,:,N'9#!VMC/7[1O]G%1V_]]RE9]VZ M'='`[_N]:KBFJ-0/>-RZWH:R&X4%/6T[@Z*HC;(P@]1&5[HN=N4BKDU=RI"UTSO M,BD911GUY\X_$GX+H.CI8Z&B@I(1B."-L;!Z@,!>R(B+_].Y41$1$1$1$1$1 M$1?A(:"YQP`,DE&1QW0N> MX]0$N25T,.4W1;C@:@IO>'#_``7U^^5HSO#2_P#5_DOS]\K1G>&E_P"K_)0; ME9UIIR_Z.%':[K%55`J6/YMH<#@`Y.\+R_<_\;U_\7_[B%)CK?2K1DZ@M^/ZPU9MJO] MIO@E-JN$-8(2!(8G9#2>"K'ELT;7W"2#4-OA=.(8N:J8V#+FM!)#@.L;SE1[ M0?*_-IRBBM-XIGU=%%YL4L9^\B'9@_B"MNR\H.EK]LMH[O"V5W^ZF/-O^!X^ MY23B,C@H%RT_[.JC^L1?WE`.12[V^R5%[K;E5Q4T#*=F7/=C/G'X M]I/$GVK/48USHBAUI:3#*!%6P@FFJ0-[#V'M:>L*@[7<]0JWM=&Z&>)VS M44[SYDS/\0>(*Z-TUJ6W:JM$=RMTNTQVZ2,_BB=UM<.U;9$1$1$1$1$1$5$\ MIU4[5?*A;].P>='3/9`0#^DX@O/N&/@KTBC;#$R*,88QH:T=@"YJY6-/"PZW MJ3$S9IZ[_68NP;7XA_S9^(4+70O(IJ$732+K9*[[^V/V`.V-V]I^.1[@O__6 MN58EUN$5JM-7<)W!L=-"Z1Q/J&50_(_:Y+_K^:\5(VFT@?4/.-QD><#]I/N7 M0:(B(B(B(B(B(B+47/4]KM-ZMUGJ97>67%Q;#&QN<>MW8,[EMT1$11?E'OGV M!H>XU3';,TK.8B_I/W?D,GW+EQ2[DNLIO6O;>PMS%3.\ID]09O'YX"Z=7R][ M8XW2/<&L:"7.)P`!UJG9;LWE.Y5**CIOO+):"9LXW2EN,N/M=@#U>U7(L*V6 M:VV9DS+;1Q4K9Y3+((Q@.>>)6:B__]>Y41$1$1$1$1$1$1$1$1$1$1$1$1%_ M_]"Y47*$T4<^OY(96!\:'TQ=="VRMK[+33U,K'%\CP2;2]LU8;U07*': M',,,4K?QQ.R=[3_^Y6)5T>I^2+4[9H9"87GS)`#S52SL<.WU<0KOT=K6UZTM MO/4KA'4Q@<_2O/G1GM]8]:DBP+U/TGL"B#;ARJ MN:";+9F^HSG/[5^^7!UM M.3O"KS3FHKUR=ZEDS$^-S'?4!E4=R24S]2\HU M=J"K87F`/GR>`D><#X`GX*^57'+9IX7323;I%'F>VOVR0-_-NW._P/N7/:G' M)#J#[#UQ!#*\MI[@/)Y.S:/X#_S;O>NDU7W+3>/L[0SJ1I^\N$S8@/YH\YW[ M`/>O/D3L9MNC#7R-Q+V+2$6*^HYRJ@I):NKF9#!"TODD>Y\CR,G?Q`&>I:31G*O?+-=H8[M6RU]ND<&RMF=M.C!/XFGCN[.M=% M-M^4N MMU/<<'R.(F*/B(]K+6M'L&TKK1$1%2G+W?-NJMUBC=NC::F4`]9W-_('XK__ MTJ95C\D^K--Z1;7U5WFF;5U&S'&(X2[#!O._UG]BGM3RY:3A?LQ17"H&SG:9 M"`,]GG.!5=ZVY6KIJB!U!0Q&W4#OQM:_,DH[''L]04YY";+Y)IRKN\C,25LV MPPD?H,_\D_!6DBC7*!J:32>DJFY4^P:G:;'`'C(+R>SKP,E4W^_?K#]:A^G_ M`/*L'DLUCJ36$M=579],VAI6AHYN+9VGG?QSU`?FM!K_`)9)XZJ6U:6D8UC# MLR5V-HN/6&9W8]?P[5";)RGZJL]Q94OND];%M9E@J'[;7CK&_A[0NDK7<8+O M:J6XTQS#51-D9[",X66M)J75UFTG1^476K#'.'W<+?.DD]@_QX*`TFM-=Z_D MD&E*&GM5#&2UU74':.>S)!W^P'':J^U->->Z>O,E#=[U7QU``<"R<[#V]1;C M=A;+3'+)J*U5D;;M.;G1%WWC9&CG&CK+7#K]15_VZOIKK;X*^CD$M/41B2-P MZP5DJM.53E$N6D:ZAH;08.>EC=+-SK-K`SAO7ZBH".6[6).`:$D__P!?_P`J MZ*>^OLFC(+OJNJBBFYH23[#-G#G;PP-XD]2J#5'+7>[G,^&Q@6RD!P'X#I7C MM).X>[XJ*0:^U93SB:/4%=M@Y\Z4N'P.Y7;R6:^J=8T-337)C!7T>R72,;@2 MM/`XX`Y'4I)JC5=KTC:S77.4@..S%$S>^5W8!_CU*C=1\L>IKQ,YE!,+72\& ML@WO(];SO^&%I[;RCZNM=2V:*]U$V#DQU#N<8[U$'_!=#:*U1'J_34%V9%S, MCB8YH\Y#7CCCU=?O6^1$1$1$7__3N5$1$1$1%RF?]HA_^[?_`)5U8B*NN7'^ M(3?ZY'^QRCW[G_C>O_B_[EJ.7G^-U%_4Q_>L[LX6V1KJ4S1$5?\J/)ZS55N-RM\0%VIF;L;N?8/ MT3Z^SX*FM%ZSN.B+UST8>^F>[9JJ5QQM@?L<.HKI:R7N@U#:H;E;9Q-3RC<> MMIZVD=1'8LXD#B0/:5^HO__4N5$1$1$1$4`Y9KX+5H>2C8[$UQD$('\T;W?D M`/>L7D/LIH-(2W&1F)+A,7-.-^PWH864BK'E+Y5&:?,EFLCF2W$C$TW%M/ZAVN_8JYY/-*5&O-5 M25-S?)-20.YZLD>XETI/!N>TG\@KAY3:F@LO)M7TQCCCCDB%-3Q-``VCP`'J M`)]RYG70_(M8*FS:2DJJR)T4EPEYUK'#!V`,-./7O/L(7GRRZPEL-CCM-#+L M5EQ!#W`[V1<#CL).[XJC]-4D=?J>V4DW\'-51L>,9R"X976X`:````-P`ZE2 M7+?J^66N9I>DD+88@V2KQ^FX[VM/J`P?:?4HKR1T3*WE&MPDQB';E`(SDM:< M?FNF%07+I9/(M44]V8/N[A%AW]-F`?R+56+07.#0,DG`77]GADIK+0P2G,D5 M-&QQ[2&@%9B+"NUVH;';)KC<9VP4\+OL`'63V+__U8'KS75;K6ZX-:"23@`=:Z?T[H*Q4&G:"EK+/1SU,<#>>DD@ M:YSGXRE*VG=!+8:(-<.,<08X>L$;PN;M3:??8]75ECB+I.:GV( M21O<#@M_(A=/Z=M++%IV@M<8P*:!K#ZW8\X^\Y6R14CR]7SG;A;['&[S8&&H ME'\YVYOY`_%5$KKMEGND^E*70U@>RGF?$VHO=6[_`''.;Q'ZW$=78.K*A7*% MR=G0T=%*VX&L95%[23%L;)&/6>W\E"0,G`XKJ_1-NEM.B[30S_PL5,W;&,8) MWX]V5J.4/E!I=&6_FH=F>Z3M^XAZF#]=WJ]76J"IF7?76K(8IYWU-;72AKI' M?HCK/J`&?@NHK+:*2PVBFM=#'L04[-EO:3UD^LG>JK_=`4L7D]FK,?>[ MUN`?VJEET5R)U;^T$^].3^TPW+4\=16N:RWVUIK*M[CN#&;\>\X"N&W6"3E%JVZBU(R06H M$_9EL<2T;'\I)VEW[/4L'E:TIIRWZ(EKJ6V4U)4PR1MB?"P,)R<$'''=GX*A ME;G)/54FD](WC5-QR&R2-IX&CC,X#.RWVD_D5(*+DZK-:572'7$\S9)F_<6Z M%VRVG9U`GCGU?%5ORHZ2MND-1Q4ELE>89X!+S<&'U1=4$>IQW?D`IHO_6N5$1$1$1$1$1$1%2)Y'-1G5)NWE%#S7E_/[/ M..VMG;VNSCA7U:KDNT)=-%ON/ MVC+3R"IV.;,+B>&H'M7Q9]+ MW'26W-];6X_[%G::L/*#2ZA M@JK_`*@@JZ!@=SD$;L9)!`W;(SO6NUOR45]]O\FH+1>3#6/+7!DV0&$``;+F M[QP[$H:CE>M43:>:@M]S#=PEDE;M>TD$9]X7K76GE-U3`ZCKZNWV.CD&)!3$ MND<.L9&?VA2+1V@;/HR!WD;73U<@Q+52@;3AV#L'J3E#TY6ZJTG+:J!T39WR ML>#*XAN`9NR^-XR"%3-1R*:@M^H'55@NE/##%)MTTLDCFR,[`<#JX>M6[8#>?LJ M-M^93"N9YKWTSB62#J=O`P3V+__7N5$15%RB[^+IIYL#/*1FJCD?L`/ M_6'MZ_7[5]:#T-KK1EQYUDM#)13.`J:4SGSA^L-VYP5C7RV&XNH"V%LG,U;' MOVCC#!G/MZMRT7V!>A75#`7>135_EI^^W@MD;AH_FEHVB/YN.M3)$1$1$1$1 M<_\`+9=S==:06FG.V*&,1[(ZY'X)_+9"N_3UK;9=/4%M:,>30,81_.QO_/*V M**BN7>P^2WJCO<4>&5D?-3._GMX?%O[%5*NKD)U&WR*OL-0\#F3Y5#D_HG<\ M>XX/O6MY/(7:OY6KCJ&9FU#3/?,W/42=F,>X;_]\TKI'N+Y'N)<3O+B5T'IBJL')?HBG9=JR.*NJ6^4 M30M\Z5[R!AH;QW#`W[E6&J=2W[E.OC8;?0U$E+"?]7I(F[6QG])Q&[)[3N"F M^A>1=M)*RXZHYN:1N]E"T[3`>UYZ_8-WM5N@!H````W`#J7-O+#725G*)6QO MW-I61Q,'JV0[]KBHSIRI-'J6V5(V?NJN-WG*_]"K]5UDE?JRZU4N M=J2KDXG.,.(`^`6_Y(:D4W*/;\MSSK9(QOQC+"NEE4O+_+$++:82XV:=SAN<1^%OO(^`*Z518=UNM%9+;-<;A M.V"FA;ESW?L':3V*B==5VH=:V:?4U1&ZAL%*]K**!_&8N=L[6.L^OAU#K5;* M^.02)K=+7&78PY]9@NQQ`8,?M/Q5IHB(HURAWO[`T1<:QKMF5\?,Q?TW[A^T MGW+EE2SDRL7V_KF@A439_59O'Q.`NGT5.U=F%Y_=#$2,VX:1D=0_L M\U@V?^K"N)%^$@#).`%RGKF]G4.L;C<`[,3I2R+^@W5=*HSE]KVR7NUT#3DP0.D:W\R52@&2!PSVJ\M`62/4- M71321\Y8M/Q\U1!P\RIJ3ODE(ZP"3CW>M6RN6^4:^=(-<7"J:[,,;^8A_HLW M?F+C\,KK2G@CI:>.GA:&QQ,#&-'4`,! M>B(B(B(B(B(B(B(B(B(B(B+_TKE1$1$1$1$1$1$1$1$1$1>-9514-%/5SN#( MH(W2/<3C``R5S;HV*35W*K35,X+Q-5NJY/8TEW^073"(HKRE6'I!H>OIV1[< M\#?*(.W:;O\`S&1[UR\LVTWBMLE4^IH9.;DDA?"XD9RUXP5>W(A9C;]'27"1 MI$EPF+QG]1OFC\]I60OPD`$DX`XE?__3KO7NH'ZEUA75^UM0M>8H!V1MW#X\ M?>L?1]BZ2ZIHK3S[H!.XYE8W)8`"WBT@C*Z_M54*ZT4=8#D3P,D&['%H/#WKEW7-"VW:WN],PQE@J MGN;S9R`''./:,KRT;6"@UE:*DEH$=7'DNX`%P!_:NL))&11NDD<&,8"YSB<` M`<2J`OQN'*[R@&"T-(M]*.;9.\>9'&#O>?63P''@KJTSIJW:4L\=MMT>&-WR M2._%*[K<5">4_E0FTQ4BS681NKRP.FF>-H0`\`!P)(W[^&Y5I0O\`"W/_`%*G%>7(-9.8M-?>Y&>?4R"& M(_S6[S\2?R5LHL""R6ZFO53>(J8-KJIC8Y9HI;U4,S!;1]V"-SI7[\/P'[5__]2F5U)RW&?>OC1.EY]6ZEIK M=&"(<[=1)C>`]975,,,=/!'!"P,CB:&,:.#0!@!57R\WGR>RT%FC?A M]5*99&C]1O#\S^2HM=%\C>G6V?1C*Y[,5-S//./\P;F#X9/O5@+F'E/O@OVN MZ^:-V8:=WD\7L9N)]YR5&K?137*X4]#3M+IJB1L;`!G>3A=96"S4^G[%26JF M_@Z:,,VL?B/6?>3P$_K'>X_#`]ZNQ$1$1$1$1$1$1$1$7_U;E1$1$1$1$1 M$1$1$1$1$1$1$6LKF7XU)-OFM[(,#`J(GN=GKWAP"Q^;U9Z39_D2^).;U9Z3 M9_D2^).;U9Z39_D2^)03E;O=\M6E/(*VIMY^TG\WLT\;VOV1O<=[CNX#WJ*\ MB='<);W<:NW/I&RPT[6$U,;G##G=6",'S5__UK*YO5GI-G^1+XDYO5GI-G^1 M+XDYO5GI-G^1+XDYO5AW&HLY'_`E\2YKUI8YM.ZKKK?,QC=E^VSFP0PM=O&S MG?C?CW+3TU/)5U45-$-J29X8T=I)P%U%;+9J6U6NEM]-/9VPTT38V#F).`&/ MUEE'G+EU2ODQK9J+7=`: M>6"*:;:A8ZH:2S+FD`'!!W\%T+S>K/2;/\B7Q)S>K/2;/\B7Q*/7[5NH+/6P M6JFDM5QNU2[9BHJ>*3::/UGG:PUH]:WT,>L.99SM39NCM1ZKU)8J+36GY(*=D%/L55P= M$[-.-X`!)P7$=@W*&\I.E)-*7BD@<87-GIPX.BVO/<"0XNVB22>*B=+*^"KA MFC(#XY&N:7<`0<[U=%56ZJY3Y)[+;:NEALL+@VJN$,;V,G/ZK>UQVMY6QYO5GI-G^1+XES+JNLJ:_5=TJ:MS73 MNJGAY9G9R#C=GJW+ZTOI:YZMN@H+9&TN`VI'O=AL;Y--!7#4E<+KS4+:*C>'--2QQCG>/T<`C('7\%>G-ZL])L_R)?$G-ZL])L_R M)?$G-ZL])L_R)?$G-ZL])L_R)?$G-ZL])L_R)?$OPLU6`2:JS@#B>8E\2YKU MC?*C4.J:VX5+V/23M<DV?Y$OB3F]6>DV?Y$OB5442<]#(7Y<`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`5337S6YU/@[0@B>U^>K!+B%M$1%CUU=2VVCDK*V=E/3Q#+Y)#A MK0H9=^6/2-LC=Y/527"4<&4[#@G^D#@>!7LBIWE[L9?#;K]$S\!--,X#J/ MG-_[OBH9R16<7;7U(YXS'1-=4NW=;=S?S(72J+SGA940202#+)&ECAZB,%J(W#^:WM=^SK72-GLU!8;;%;K;3M@IXA@`<2>TGK) M[557[H"ES!9JSS=SI(SNWG@?AN49Y.N2ZJU1(RY75DE-:!O:1N?4>IO8/7\% MT%14-+;:.*CHH&4]/$T-9'&,!H7NBYSY6M&UEBU)47:.'-MKY3(R1@W1O.\M M/9OR0L;DGU11Z7U89+A((J6KA,+Y2,AAR""?5D*\KER@:5M=*ZHFO=))AI+8 MX)!(]^.H`=:K>FT=>N5'4[M17V&2V6G<(8G#$CXQP:.S.\EQ[=RN2BHJ:W44 M5'1P,@IX6AD<;!@-`7NB+__2N5:*_:TT]IF017:Y1P3.9MMB`+GD=N`/4JQU MKRUQUM!/;=-P2Q\\W8=63``AIX[+>WUGX*GT!+2".(5N:?Y=ZFEIXZ>^6P5. MP`WGZ=VRX^LM.XGWA3>@Y8=&UP&W7R4CCQ;/"X8]XR%,*&NI;E1QUE%,V>GE M&62,X.':%D(BY9Y0[W]OZXN58U^U$V3F8C_,9YH^."?>L71ME.H-6VZVX)9+ M,#)ZF#>[\@5U>UH:T-:,`#``ZE^HBYQY7M+5%DU=/<6Q.-#<7<['(!D!Y_$T MGMSD^PJ"12.AE9*PX>QPAKZVYL@J!$.>IB"9`\#>`.O? MP*K2YLU-RQZCYZ@I'P6RG.Q$Z4D1Q-SO<3UN/6!GJ5MZ*T%:M%T6*=O/UL@Q M-5O'G.]0[!ZOBI0L"^7-EFL5=:AW]'@W\AGWJ>*AN76RUL6HZ>\EA=1U$ M#8@\<&/;G9.W1VX@!D9_6:%]#<:9M33/(+HWYP<'(X>M:F#0.D MJ9I;'IZAP3D[40=^U>O0G2W=^W?3M_R3H3I;N_;OIV_Y+PFY/-'U$FW)IZBV ML8\UFR/@%OJ:GAHZ6*FIXQ'#"P,C8.#6@8`^"]46OOMCH=1VB:UW&,OIYL;0 M:<$$'((/4HFM4^FE+2X,>6G(.1O]RR+? M;J.U4,=%04[*>GB&&1L&`%DK3Z@TM:-3BD;=J<8S:(!.,8/:%MHXXX M8FQ1,:R-@#6M:,!H'``+Z1?_U;E7E4TM/6T[Z>J@CGAD&'QR-#FN'K!4,K^1 M_1E=/SHM\E,3Q;3S%K3[CG'N6RLO)UI6P2MFHK3&Z=HW2SDR.'K&=P/L4F1$ M1%I+IHS3EZK75MSM,%54.`:9),YP.`XKSAT)I.",1QZ>H-D;_.A#C\2OOH3I M;N_;OIV_Y)T)TMW?MWT[?\DZ$Z6[OV[Z=O\`DL9_)SHV1[GNT]1Y<=;:_*7@Y!JGF0#W9LUQM=+5R,;LM? M-$'$#LWK$Z$Z6[OV[Z=O^2W$$$5-`R"")L44;0UC&#`:!P`"]%__UK>K:&DN M5))25M/'44\HP^.1NTUWN4+JN1K1E3.96T=1!G]"*LK]!#@"# MD'>"%X,KJ.2K=1LJH75+!M.A;("]H[2.*]9)HHBT22,87NV6AS@-H]@[2DTT M5/"Z:>5D4;!ESWNP![2ORGJ(*N!D]--'-$\9;)&X.:X>HA?E14P4D#IZF:.& M)F]TDC@UH]I*\*.[VRX2&.BN%-4/:,EL4K7$#V`K,1$1$7__U[E7E45,%)`Z M>IFCAB8,NDD<&M;[25X4=XMEPD,='<*:H>!DMBE:X@>P%9B_'.#6EQ.`!DKP MH:ZFN5%%6T]9"(B(B(B(B(B(B(B(B(B(B(B__0N5$1$1$1 M$1$1$1$1$1$1$1$1$1$1?__1N5$1$1$1$1$1$1$1$1$1$1$11?E"H*:ITA7#(#HB1C/^]9U+776F.HKY8Y;);IZ0 MT%6)JBMDIS`&Q@;XQM`%VUD;L86PM6H;IBI1;RT2OHVD\\R$_I[?`N`W[./5G*]:G4M;5ZBEM%F M=0B2FBBF",4L$4OEQPR<8!R'9WX.Y?=ONFI+M;X+O24E"RFG.U% M23.<)'1$[G%XW!Q&_9P>/%8]GGO=3K^^"2:G-!3 MQ>O*3CH'<2X9`YLD8S_O&K5WV":_W2SS:=M,L,UOJN?DJIH33-#`#F/+@"=K M(ZB`MS17JYP:ICLET-%-Y33/GBDI<@QEI`;U55AC MIJ2&@HJRHI9BYSC)(&9`+>H;\9RL+1UTJ#I>QVZV113S\R'5,CW>93,R>..+ MCU-]YW!;:EU*XU]]HJV%L4EJ+7Q[)/WL3FY:[VY!"Q[?JJIN&FJ2M;1LCN,] M5Y(^F<3LQ2AY#P3QP`"4U)>[U8:6HNSHZ`4%*\9@JFU05]`RAAML[*B:82 MM>)GM;@-C`X-R8&.&[M.2%FW.JN- M(8I*&W"NCWB5C90R0=A;G\W`,BJ+G(S$$;]IL4;&[+&T5*U\3 M7M:\GSL.!=N[-@8)QQ/J6 MSH*`U9ECGTU2VN"2%\4C@YAD<3NPW8'X<9WDYX;EY69FH+3;(+*;=#,ZD8V* M.M,P;$^,'`);^(.V>(QC/6O:WT%PM^K[K4&F$M%PK16?25WTW!;*VU"G%6(VPW6DV\1U+0=SP< M;GM[>L;BMO>-/55?J:WW*GD9'3\V8;@QW&2-I#V`?VQO]1*_+?IZKI-8U]P= M)']G2'GX(@?.$[VALCCZL-'Q*T=STM>;E#J&@GHH:B:N>Y]+*6IB-)EVT!([S7,R.(+2?@I);Z*&VT$- M%3MV8X6!H]?:?:3O60B(B(B(B__6N5$1$1$1$1$1$1$1$1$1$1$1$1$1?__7 MN5$1$1$1$1$1$1$1$1$1$1$1$1$1?__0N5$1$1$1$7A-6TE._8GJH8G$9P^0 M-/YKUCDCFC$D3VO8[@YIR#[U](B\*JMI:&+G:NIBIX_UI7AH_-?M-64M;%SM M+413L/Z43PX?DO9>$=;2S54]+'.QT],&F:,'?'M#+\K.1>514P4D1E MJ9HX8QQ?(X-`]Y7Q27"BN#-NCJX*EHXF*0.Q\%\5EVMMN<,#G`%Q]7:OV6:*!FW-*R-@_2>X`?$KY@JJ>I!-//%-L\>;>'8^"_65$$ MDKXF31ND9^)C7`EOM'4L*OIZ`W"BK:VI;&^E+S"Q\@:TN<,%V#Q(!('M*SHI M8IXQ)#(R1AX.8X$'WA?:+__1N5$1$1$1$1$1$1$1$1$1$1$1$1$1?__2N5$1 M$1$1$1$1$1$1$1$1$1$1$1$1?__3N5$1$1$1$1$1$1$4%KI;7%RDW`W.A-6T MVRGV`*0S[/GR9X`X6XEN_,3T=HT_;XN?J(75&)6F**GCSC:PXS@X/$9!&%KM1WO4S;+%)#1049K:VG MBIG-J3MAKW#\?F[B>!QP!ZU,Z5U0^FC=51,BG(\]C'[36GL!P,_!0[1T,.I: MZZ:DN43:B45LE+1LE&T*:)AQAHX`DY)/6M]61VC35/7WT4;(7"+,YA8`9U8;M07>WFDJ;Q;(8**LE9%F&4NDI7/W-YS(P03@$C@3UKSLW\>M5_ M\.C_`/\`-ZU%EK::W\D=NFJZ&.NA+V1N@DQLG:GV0=X/`G/N4CK[Y61:CCL5 M!0LEEDI#4\_))LLC`=L^<`,GW+!Z:>2:?N5=&7[4IZ:)[7XC?32E[)68!#AD9''&/4M@H39X8]3:UOE9< MV-J(;1.VDHH)!ED1#*>WV*BN&HH*"%M72T,XR>#1D``;MRQ:2-FF^4:.U M4#1%;KO1OG\F;N9%,PC+FCJ!!W@=84BU#'5RZ=N,=#.VGJ74SQ%*YVR&.P=^ M>KV]2__4DMFEM=5?]/?8\3K<^.E>ZH#V&(U+-D#8&1]Z=KSMH9QC.=ZS[#;J M/5,=YK[O3LJ7S5LU+&)!DPQ1G8#6G]'>"[(P]NT1U[@.*D]BJ+)7PU8M-.VCE8>:JHFPL+57.Q76^6W4=<:'F*JY4K*6CIGR#;YMN2"_J! M)<=V=PPMGJBVUM3I^@%+`9YJ"JIZE\+2-I[8R"X-ZL]BD4,AEA9(8WQ%PSL/ MQM-]1PHI1T5QTAS2T314125\TKV\ MV&L<'XB(.7Y+0,X&!Q6QMMLJZ?56H*Z6,"GK64P@=M`[6PQP=NZMY"TC=-W4 M=_#\.]?_7LLVZJZT/Q\YM8QQ MX+6-MM70T^HG5-F%R@K[AS@I@]I,L)8QI.#NR,'<<9PL.U0U6E+1W4;[ MA0739?54T3@V6&1HQML!P'`CB,@Y6TBGFOT,]+4VB>FH)H'1O-46M>\G=@,! M.[&=Y*U-EGO.E;='9J^U55RAI1S=-646R\RQC\(>TD%K@-W6#A>]HM5QKM32 M:EO%.VD>RG\FHJ/;#W1,)RY[B-VT3NP.`'%;'5-JFO>F:ZVTT@CFGCPPDX!( M(.R?4<8/J)6JDAKM07.S\Y:);:RUS\_-)-L_B#"WFX\$Y!SO.X8"\Z!MVTQ4 MW6CAM$U=3U56^IH7P.;LM+][F29(+0'9W[]Q65;8Z_2MEHJ1UMEN/FODJYJ0 MM+A*YVT<,.,@DGAPPORSVZNBN]YU+4T3XYZV..."B$C=O8C!QM'.SM.)[=P7 ME9GW9MQ-?<=.U(KJG$=S&^=G9'$[LD[^S&TK;Q<**KEA;8:NJ8< MH9PMXB(B M(B(B(B(B(B(B+__0N5$1$1$1$1$1$1$1$1$1$1$1$1$1?__1N5$1$1$1$1$1 M$1$1$1$1$1$1$1$1?__2N5$7XUP<`6D$'@0C7!PRT@CM!7Z@((R-Z<4.X9*( MOA\4'%?J(B(B( MB(B(B(B__].Y41$1$1$1$1$1$1$1$1$1$1$1$1%__]2Y41$1$1$1$1$1$1$1 M$1$1$1$1$1%__]6Y41$1$1$6EU77OH;(60R&.>LFCI(G@X+72.#5G6F9E%JBYV1IQ&6,K8&=3 M0\D/`[!M#./YQ7CK*IDC-HIGRN@H*NO;%62AVQAFRXAI=U!S@T'VXZUC4U10 M6K7=):;2[9AJZ65U1!&XF)CV[):X=0<03D#JP5A7O1%FI(64MN;6QUM?*60A MM?,&L)WO>0'<&C)]N!UK.J*:.OU92ZNGF&U:KO%CB>]U&(XJNGC4PD^;#ETF&#V`#/:! MQ`X[^'8FB6S"P%SZATU.^HE=1[L@>\<%L[Q9Z.^VY]!7L>^!Y M!(9(6'(.1O!RHU:M,VV+5O.6]];S5L!$QDK)9&OF>@#/.?)OWD.Q@GK*FZ(B(B(B__]:Y41$1$1$1 M$1$1$1$1$1$1$1$1$1%__]>Y41$1$1$1$1$1$1$1$1$1$1$1$1%__]"Y41$1 M$1$1$1$1$6CU?1/J[()8F)H(; M<\U5#)6T[B&RPQP\Z2#U[/6%IK%;W3WO[2CMOV;;J:G,-%3NC#'.+B"^0M'X M>#0`=_%9=JI*FJO57>J^-\1WTU'`_P#W<0.]^.UYW^P-6)=HJNU:QI[]%1S5 M5'-1NI:L0-VY(R';3'!O$C>X'':OVV6R6[7&[7:OIYZ6*N9'3T\>T8Y1"S)R M<;VDN<3CCC"S)M*T,U'%2^4U[&13BH:X53R[;'#>XDX'''#*U5KTW54>OJRO M=4W"2E\BA:R66?:$C@Y^6GM`!!]Z^;Q&RZR5=);;!+3W6I!IY:^6E#&Q,.YS M^<_2\W.,9)W<%NIZ]MB%-0LME;-3,A:R.6GBYP`C<&D#>-V-_!:W2EAJ8+)< M(KE')2BY5LM2VECEV33,>= MPR7'^>8C?+(XY<[WD_L4?%QJ:N\BON.GKN6TCW M-HH6PM+6]1E/G;W$$#:=@8#1E1^PU4SKB:VOLMT9<:T!DDKXF\U3LX MB-IVMS1UG&\[U*U__]&Y41$1$1$1$1$1$1$1$1$1$1$1$1%__]*Y41$1$1$1 M$1$1$1$1$1$1$1$1$1%__].Y41$1$1$1$1$1$1$1$1$1>3Y*>AIG22/BIX(Q MDN<0UK1^P+[C;&R-HB:T,X@-&Y?2(B(B+__4N5$1$1$1$1$1$1$1$1$1$1$1 M$1$1?__5N5$1$1$1$1$1$1$1$1$1$1$1$1$1?__6N5$1$1$1$1$1$1$1$1$1 M$1$1$1%J-47"2W65Y@DYNIJ9&4T#NQ\C@T$>S)/N6BOTAHKYIZPLM$U;08D+ MF.+'-E+6;L[1W[.=HY]6%__7L:S2LH+_`'&PAWW;&,JZ9A.=ECR0X#U!P/\` MS+XU;65$,EHH8YGTT%PKFP5$[';+FLV7.V0[JVB`W/KW+'IYZ>RZWI;)15$K MH:REDDDIGRF00N:00X%Q)&03N]65@7G2D5NI1#;KS>Q65DI931?:#MD/.\N/ M\UHR3[,=:SJF-]?J:DTR^HG-#1V\5%1]Z6OJ'%VPP.<-Y&YQ.\9.%ZZ>=-;M M2W:PNJ)9Z:)D552H!133 MU37SZ\NCJV60"6WT\S*9Q\V`%SP&X[<`9/:2M1M36NN,UMM<)E#9;A,&Q1QMX23$=7\T;R3U`%:K0?E(M MUSBJZN2KEANM1&99#O=@CX#U!9.L:RHI;92Q05#J9M96PTTU0PX=%&]V"0>H M]6>K*P9IJ;3FL;1;:*HF++F)6S4SYG2!I:W:;)YQ.#D$>O/J6(!IVHU!=(+W M5%E5)6\W"'U,D8V=AF`,$-&_.%LKS*^LU+;--MDECI7T\E34ECRUTC&8:UFT M-^"3D^Q?EH;)9]85EE9/-)1S4;:NFCDD+^8(<6.:"=^#N./:M;HV/3M72V_- M2YUX9&)7M?4R![G`[S@G#O7Q4Y1$1$1$1$1$1$1$1?_0N5$1$1$1$1$1$1$1 M$1$1$1$1$1$1?__1N5$1$1$1$1$1$1$1$1$1$1$1$1$1?__2N5$1$1:'65(^ MHL;)XV%[J"JAJ]D'B(W@N_+*^;I!+5:LTY64\;I::-M27RL&6M#HQLY/KZDM M],VIUI<[JTG9AIXZ('.YS@2]WPVFCXK/OKKL^UP5-POE3 M>:R.2**+--0PR-P0P'SY,=KCN'J:.U8=U,MFUM3WM]/+)05-":6IEC87F!S7 M;3"0-^#DC/L2UT4MYNMWN\@J:*"KCBIJ1[HJRNN$8J+A/L M$EK'$%P(E:0.)^'J6WFHJ.U6:I9<)*RY4DF.=;4YJ"&\.&,XZ]P6HL]MHJN_ MTU7;+8Y)(BPU$SQLY`=YQ#6@C)_6W+XU/KC;2TK6Q$25`VMI[FL.#C.`,\<%8MW(U7=K&V MTPU#/L^L%3/5/@=%S+`"#&"X`DNR!@=7%31$1$1$1$1%_].Y41$1$1$1$1$1 M$1$1$1$1$1$1$1%__]2Y41$1$1$1$1$1$1$1$1$1$1$1$1%__]6Y41$1$1$1 M$1$(R,'>%\0PQT\38H6-CC8,-:T8`'J2*&*"/FX8VL;DG#1C>3DE?:(B9&<9 MWHB+\!!X%?J(B(B(B(O_UKE1$1$1$1$1$1$1$1$1$1$1$1$1$7__U[E1$1$1 M$1$1$1$1$1$1$1$1$1$1$7__T+E1$1$1$1$1$1$1$1$6+(V[3MD;S@=:Q:O4=LHJ6WU4T^(KE+'%3N`R'%XRW/8/6OVXW^CMCZEDS M)GFEI35R\TS:V8P2/CN.[U%*K4-MHZ6WU4TV(KC+'%3N`SM%XRW/8/6OVXWZ MCMCZELS9GFEI35RB)FUB,''QW'`]17S5ZBME%26^JFGQ#XMJXJ@`.AP-K)P2",;P0O&BU725E32Q M/I*RE97@FCFJ(PUL^[.!OR#C>`[&0OJEU/35MT;1TU)5RPOD?$VL9'F$O9G; M;M9W8QC.,$@@<%J-,W:GM5@K)ZITCB^[5,<4;&E[Y'F4X:T=96ZN5_%O):RV M5U6YD7/2B",'FV^LD@$[CN&3N6?05U/.L$+$N5]@M]9% M0,@GJZV9AD93P-!.R-Q<22`T9W9)XK__T;,?JB@@M+[C5155,UDP@,,L!$ID M)`#6M_2))&,9"^K?J*&KN/V;4TE305KHS+'#4-'WC`<$M()!QD9&M9'))RA6>H9%(81;Z@%^P<-)='@$]16EN%GK;H_7=)!'(V2K;`('$$"0B M(;@>OACWKVMD-DN-5;=JX7NHJ89FRBCJ)'N\GD:#_"#`#<;QOX]2Q;5L4FIH M!I:X5;Z>KK'NN-LJ(CL4S=Y<\9&6$N`P,[]I8UM@NMAG?J`4M36TC*^JBJ*, MLRZ!CI3]_$.)/;QR."WEROLTVHWVZ6KGHJ&6C;)1N@A)?6/=D.`<0<;/F[L`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` end
-----END PRIVACY-ENHANCED MESSAGE-----